The salvage potential of coronary sinus interventions: meta-analysis and pathophysiologic consequences  by Syeda, Bonni et al.
Cardiopulmonary
Support and
PhysiologyThe salvage potential of coronary sinus interventions:
Meta-analysis and pathophysiologic consequences
Bonni Syeda, MD, MSca
Christoph Schukro, MDa
Georg Heinze, MScb
Kourosh Modaressi, MDa
Dietmar Glogar, MD, FESCa
Gerald Maurer, MDa
cWerner Mohl, MD, PhD
CS
PSee related editorial on page
1549.
From the Departments of Cardiology, Inter-
nal Medicine II,a Medical Computer Sci-
ences,b and Cardiothoracic Surgery,c Uni-
versity of Vienna, Vienna, Austria.
Sponsored by Fonds zur Fo¨rderung der wis-
senschaftlichen Forschung (Austrian Sci-
ence Fund, FWF Nr. P13274-MED) and
The Society of Coronary Sinus Interven-
tions (www.coronarysinus.com).
Received for publication Nov 20, 2003; re-
visions received Dec 22, 2003; accepted for
publication Jan 28, 2004.
Address for reprints: Werner Mohl, MD,
PhD, Department of Cardiothoracic Sur-
gery, University of Vienna, Waehringer
Guertel 18-20, A-1090 Vienna, Austria (E-
mail: werner.mohl@univie.ac.at).
J Thorac Cardiovasc Surg 2004;127:
1703-12
0022-5223/$30.00
Copyright © 2004 by The American Asso-
ciation for Thoracic Surgery
doi:10.1016/j.jtcvs.2004.01.036TObjectives: Intermittent coronary sinus occlusion has been described to be effective
in salvaging ischemic myocardium. This meta-analysis aims to review the efficacy
of intermittent coronary sinus occlusion and intermittent coronary sinus occlusion in
combination with retroperfusion of arterial blood as methods of myocardial salvage.
Methods: A Medline search was performed to review the published literature on
intermittent coronary sinus occlusion. The study inclusion criterion was a random-
ized, placebo-controlled trial with area of infarction (expressed as a percentage of
the area at risk) as the primary end point.
Results: Seven experimental trials comprising 125 test animals were found that
analyzed the effects of intermittent coronary sinus occlusion on ischemic damage
during coronary occlusion. A further 5 studies comprising 88 animals were designed
to evaluate the effect of intermittent coronary sinus occlusion in combination with
retroperfusion of arterial blood on the infarct size. A meta-analysis of the 7 studies
analyzing the effect of intermittent coronary sinus occlusion revealed a significant
reduction in infarct size of 29.3% in the treatment group compared with that in the
placebo group (P  .001; 95% confidence interval, 40.9 to 17.7). A meta-
analysis of the 5 trials analyzing the effect of intermittent coronary sinus occlusion
in combination with retroperfusion revealed a reduction in infarct size of 39.4% in
the treatment group compared with that in the placebo group (P  .001; 95%
confidence interval, 48.9 to 29.9). Comparison between intermittent coronary
sinus occlusion and intermittent coronary sinus occlusion in combination with
retroperfusion of arterial blood showed no statistical difference (P  .19). An
inverse relationship between achieved coronary sinus pressure increase per minute
and infarct size could be found in the intermittent coronary sinus occlusion group
(r  0.92; P  .007), whereas in combination with retroperfusion, there was a
negative correlation both between achieved coronary sinus pressure and the amount
of the retroperfusate and myocardial salvage (r  0.97; P  .004).
Conclusions: The use of intermittent coronary sinus occlusion and intermittent
coronary sinus occlusion in combination with retroperfusion of arterial blood
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CSPsignificantly decreases ischemic damage during coronary occlusions. Intermittent
coronary sinus occlusion in combination with retroperfusion exhibits no significant
profit in salvaging the ischemic myocardium in comparison with that provided by
intermittent coronary sinus occlusion alone.The concept of arterialization of the cardiacvenous system to increase the flow of oxy-genated blood to ischemic myocardial tissuewas suggested more than 100 years ago1 andhas since been modified with the develop-ment of new technologies. Initial attempts of
permanent retroperfusion of the coronary sinus by means of
anastomosis to an arterial vessel were soon truncated be-
cause of ultrastructural damage of the wall of the coronary
sinus caused by drainage disruption.2,3 Moreover, with the
birth of the coronary artery bypass grafting era and the
further development of percutaneous transluminal coronary
angioplasty, the concept of selective retroperfusion was
discarded. Attempts to introduce coronary sinus interven-
tions clinically by interventional cardiologists also have
been abandoned.
The advent and current praxis of off-pump revascular-
ization and its potential benefits through avoidance of ex-
tracorporeal circuits again draws interest to myocardial pro-
tection through the coronary sinus. It is well understood that
occlusion of a coronary vessel might create regional isch-
emia and subsequently cause an inflammatory response.4
This might be one of the reasons why the clinical benefits of
this procedure are still difficult to detect.5
Several retroperfusion methods have been advocated to
ameliorate myocardial ischemia during off-pump surgery.6,7
Lazar and colleagues8,9 also suggested that the simple
method of transient coronary venous pressure increase
caused by coronary sinus occlusion might at least be equiv-
alent to that seen with retroperfusion techniques. There is
ample evidence that coronary sinus intervention salvages
ischemic myocardium during myocardial infarction.10-12
Although intermittent coronary sinus occlusion (ICSO),
pressure-controlled intermittent coronary sinus occlusion
(PICSO), synchronized retrograde perfusion (SRP), and
simplified retroperfusion (SR) have all been described to be
effective in salvaging ischemic myocardium in several ex-
perimental models of coronary artery occlusion,13,14 the
mode of action of these interventions remained speculative.
The common denominator of all coronary sinus interven-
tions is the temporal increase in coronary venous pressure
through temporal occlusion of the outflow, retroperfusion of
arterial blood, or both. ICSO is a simple method that oc-
cludes the coronary sinus intermittently through inflationr that is positioned
iovascular Surgery ● Junin the orifice of the coronary sinus. This results in a redis-
tribution of coronary sinus blood flow within the venous
compartment to the ischemic myocardium through changes
in pressure gradients throughout the coronary venous sys-
tem.15 The balloon catheter is connected to a pneumatic
pump that automatically increases and decreases pressure in
the coronary venous system according to a preset cycle. The
SRP and SR systems are modified ICSO techniques that
actively pump arterial (SRP) or venous (SR) blood into the
coronary sinus and have been used clinically for myocardial
protection during high-risk angioplasty.16,17 Systems using
selective retroperfusion and synchronized suction of the
oxygenated blood represent an extended version of the SRP
technique.18 Further developments include the left ventricle
to coronary sinus shunt, which is a left ventricle–powered
system that provides a graded systolic retroperfusion of the
coronary sinus.7 Experimental and clinical studies have
previously demonstrated all these techniques to significantly
increase blood flow to the ischemic myocardium and thus
reduce infarct size.7,13,19,20
The aim of this study was to systemically review pub-
lished evidence of coronary sinus interventions in the med-
ical literature and to perform a meta-analysis of available
randomized trials to assess the efficacy of ICSO-PICSO and
ICSO in combination with retroperfusion of arterial blood
as myocardial salvage in terms of reduced infarct size.
Furthermore, we sought to perform a comparison between
both procedures and to draw pathophysiologic conclusions.
This evidence-based analysis could be the basis for match-
ing an old and almost forgotten but attractive concept of
myocardial protection and the new techniques of off-pump
surgery, thus clarifying the clinical benefit of both proce-
dures.
Methods
Identification of Trials and Inclusion Criteria
A Medline search was conducted for all articles published until
2003 which assessed the effects of coronary sinus interventions on
myocardial salvage during acute ischemia in experimental and
clinical trials. The following terms were used for the search: (1)
“pressure-controlled intermittent coronary sinus occlusion” (37
reports identified); (2) “intermittent coronary sinus occlusion” (42
reports identified); (3) “PICSO” (15 reports identified); (4) “ICSO”
(12 reports identified, of which 8 are related to the cardiovascular
system); (5) “coronary sinus retroperfusion” (73 reports identi-
fied); (6) “intermittent coronary sinus retroperfusion” (16 reports
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ports identified). Relevant articles were identified from the title or
abstract (when available) for further review. Bibliographies of all
retrieved articles were evaluated for other relevant references.
Multiply yielded reports were considered once such that a total of
100 articles remained for further review.
Two authors independently evaluated all 100 relevant reports
identified by the searches. The study inclusion criterion was a
randomized, placebo-controlled trial with area of infarction (ex-
pressed as a percentage of the area at risk) as the primary end
point. Studies with application of ICSO without other techniques
except for retroperfusion of arterial blood were included in the
analysis. Reports of ICSO and ICSO in combination with retroper-
fusion of arterial blood were handled separately for a separate
analysis. All information retrieved from the reports were tabulated
by one reviewer and subsequently confirmed by a second reviewer.
Data Extraction
The following information was assembled for each study: (1)
publication data, first author’s last name, and year of publication;
(2) study design; (3) characteristics of treated versus placebo group
(including number of subjects in each group); and (4) target
parameter as area of infarction (expressed as a percentage of the
area at risk), including mean values and either SD or SEM. All
reported SEMs were converted to SDs as follows:
SD SEMxn. (1)
Statistical Analysis
All similar studies were pooled by using weighted mean differ-
ences, with 95% confidence intervals on the basis of normal
distribution. Heterogeneity of study results was tested by estimat-
ing the between-study variance (BSV) by using restricted maxi-
mum likelihood and testing the null hypothesis of a BSV of 0; a P
value of less than .05 was considered as indicating the use of
random-effects models. Comparison between the weighted mean
differences of ICSO and ICSO in combination with retroperfusion
of arterial blood was performed by using a z test.
The linear regression test of Egger and associates21 was used to
test the null hypothesis of the absence of publication bias. This test
performs a linear regression of the standardized effect estimates
(mean difference/SE) on SEs of all trials. The estimated intercept
parameter is then used to measure asymmetry, with a significant
difference from 0 being assumed to indicate publication bias. A
negative intercept is considered to indicate smaller studies to be
associated with bigger effects.
To determine the range of results that would be obtained with
varying plausible assumptions, we evaluated the sensitivity of the
weighted results on the basis of (1) omission of particular studies
and (2) varying the assumptions on BSV. By using the jackknife
technique,22 the analysis was repeated multiple times, with the
data from a single study removed each time from the data for the
entire group of studies. This allowed us to determine the influence
of each single study on the pooled result. In a second sensitivity
analysis, we used the Thompson plot,23 which indicates the effect
of the choice of statistical method on the analysis. To construct a
Thompson plot, the analysis is repeated by changing the percent-
age of weight allocated to each trial from allocating equal weight
The Journal of Thoracicto each trial, which corresponds to assuming infinite BSV, to
weighting each study with the inverse of its variance, correspond-
ing to assuming zero BSV. Although the y-axis of this plot
corresponds to the pooled mean difference, the x-axis represents
the following: Assumed BSV/(Assumed BSV  Estimated BSV),
and thus the value 0 of the x-axis corresponds to a fixed effects
analysis, and the value 1 correlates to equal weighting of all
studies. The Spearman nonparametric correlation coefficient was
computed from the study means. SAS System Version 8.2 (SAS
Institute Inc, Cary, NC) was used for statistical analysis.
Results
A total of 100 potential articles were identified from the
Medline search and bibliography review. Eleven studies
were designed to have a primary end point of area of
infarction expressed as a percentage of the area at risk. Two
of these trials were excluded from final analysis because of
application of ICSO in combination with other techniques
(Lazar and colleagues24: ICSO in combination with intra-
aortic balloon pump; Lazar and colleagues25: ICSO in com-
bination with percutaneous bypass). A further 2 studies
were designed to assess the efficacy of ICSO in combination
with retrograde perfusion (Ropchan and coworkers26: ICSO
in combination with intermittent coronary sinus retroperfu-
sion; Martin and associates7: ICSO in combination with left
ventricle to coronary sinus shunt). Consensus was reached
between the 2 reviewers for final inclusion of the remaining
7 trials in the meta-analysis analyzing the efficacy of ICSO
in reducing infarct size. A total of 125 subjects were in-
cluded in the analysis. Details regarding the included studies
can be found in Tables 1, A, and 2, A.
Of the 11 trials designed to assess the area of infarction
as a primary end point, 5 studies were designed to evaluate
the efficacy of ICSO in combination with retroperfusion of
arterial blood on reduction of infarct size (thus 3 studies
analyzed both the efficacy of ICSO and the efficacy of ICSO
in combination with retrograde perfusion). These 5 studies
were analyzed in an additional meta-analysis, comprising a
total of 88 animals. Details regarding the included studies
are tabulated in Tables 1, B, and 2, B.
The meta-analysis of the 7 studies analyzing the effect of
ICSO on the infarct size revealed a significant reduction in
infarct size of 29.2% in the treatment group compared with
that in the placebo group (weighted mean difference be-
tween the ICSO and control groups,29.3; 95% confidence
interval, 40.9 to 17.7; P  .0001; Table 3). The test of
heterogeneity indicated a significant difference of BSV
from zero (P  .0001), thus implying the use of a random-
effects model. The linear regression test of Egger and as-
sociates21 revealed a negative yet not significant intercept
term in the linear regression test for publication bias (inter-
cept,13.2; P .16). Thus the linear regression test shows
a tendency of publication bias and overestimation of the
pooled mean difference; however, this trend is not signifi-
and Cardiovascular Surgery ● Volume 127, Number 6 1705
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using the jackknife sensitivity analysis is calculated as
TABLE 1. Summary of study design
A. Intermittent coronary sinus occlusion
Source
Duration of occlusion/ICSO/
reperfusion
Mohl and coworkers, 198420 15 min after CA occlusion:
6 h ICSO, no reperfusion
Zalewski and coworkers, 198527 3 min after CA occlusion:
6 h ICSO, no reperfusion
Guerci and coworkers, 198736 30 min after CA occlusion:
2.5 h ICSO, followed by
8–12 d reperfusion
Ikeoka and coworkers, 199014 1 h after CA occlusion: 3 h
ICSO, no reperfusion
Feindel and coworkers, 199134 Immediately after CA
occlusion: 4 h ICSO,
followed by 1 h
reperfusion
Lazar and coworkers, 199237 Immediately after CA
occlusion: 90 min ICSO,
followed by 30 min
ischemic arrest and fina
1 h reperfusion
Aldea and coworkers, 199613 Immediately after CA
occlusion: 90 min ICSO,
followed by 60 min
cardioplegic arrest and
final 3 h reperfusion
B. Intermittent coronary sinus occlusion in combination with retroperfus
Source
Duration of occlusion/ICSO 
retroperf/reperfusion
Feindel and coworkers, 199134 Immediately after CA occlusion
4 h ICSO  retroperf,
followed by 1 h reperfusion
Lazar and coworkers, 199237 Immediately after CA occlusion
90 min ICSO 
retroperf, followed by 30 min
ischemic arrest and final 1 h
reperfusion
Ropchan and coworkers,
199226
Immediately after CA occlusion
4 h ICSO  retroperf,
followed by 1 h reperfusion
Aldea and coworkers, 199613 Immediately after CA occlusion
90 min ICSO  retroperf,
followed by 60 min
cardioplegic arrest and final
3 h reperfusion
Martin and coworkers, 20007 5 min after CA occlusion: 1 h
ICSO  retroperf, followed
by 3 h reperfusion
ICSO, Intermittent coronary sinus occlusion; CA, coronary artery; Retrope33.2 to 26.2 (weighted mean difference between the
1706 The Journal of Thoracic and Cardiovascular Surgery ● JunICSO and control groups remained significant for all jack-
knife calculations, P  .001). The Thompson plot showed
Duration of inflation/deflation
Achieved coronary sinus
pressure
15.0  3.0 s/4.0  2.0 s Mean, 44.0  7.0 mm Hg
15.0 s/4.0 s Peak: 59.0  4.0 mm Hg
10.0 s/5.0 s Peak: 43.0  5.0 mm Hg
13.0  3.0 s/5.0 s Peak: 56.0  7.0 mm Hg
5.0 s/5.0 s Mean: 17.1  6.4 mm Hg
8.0 s/4.0 s Peak: 52.0  3.0 mm Hg
10.0 s/4.0 s Peak: 40–50 mm Hg
f arterial blood
Duration of
inflation/
deflation
Achieved coronary sinus
pressure Rate of retroperf
.0 s/5.0 s Mean: 56.1  5.4 mm Hg 60.0 mL/min
.0 s/4.0 s Peak: 45.0  4.0 mm Hg 7.0 mL/min
.0 s/5.0 s Mean: 51.0  12.0 mm Hg 60.0 mL/min
0.0 s/4.0 s Peak: 40-50 mm Hg 50.0-200.0 mL/min
ot
described
Mean: 15.0 mm Hg 111.0  47.0 mL/min
roperfusion of arterial blood.l
ion o
: 5
: 8
: 5
: 1
N
rf, retsome dependence of the weighted mean difference on the
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effects analysis with a weighted mean difference of 24.8;
however, the significance between the ICSO and control
groups remains, P  .001; Figure 1).
The meta-analysis of the 5 trials analyzing the effect of
ICSO in combination with retroperfusion of arterial blood
revealed reduction in infarct size of 39.4% in the treatment
group in comparison with that in the placebo group
TABLE 2. Effects on myocardial infarct size
A. Effects of intermittent coronary sinus occlusion on myocardial infarct
Source No. of subjects (ICSO/contr
Mohl and coworkers, 198420 13/12
Zalewski and coworkers, 198527 9/9
Guerci and coworkers, 198736 7/7
Ikeoka and coworkers, 199014 8/8
Feindel and coworkers, 199134 10/10
Lazar and coworkers, 199237 10/10
Aldea and coworkers, 199613 6/6
B. Effects of intermittent coronary sinus occlusion in combination with r
Source
No. of subjects
(ICSO  retroperf/
control)
Feindel and coworkers, 199134 10/10
Lazar and coworkers, 199237 10/10
Ropchan and coworkers, 199226 13/12
Aldea and coworkers, 199613 6/6
Martin and coworkers, 20007 6/5
ICSO, Intermittent coronary sinus occlusion; Retroperf, retroperfusion of a
TABLE 3. Effects of intermittent coronary sinus occlusion(weighted mean difference between the treatment and con-
The Journal of Thoracictrol groups, 39.4; 95% confidence interval, 48.9 to
29.9; P  .0001; Table 4). The test of heterogeneity
indicates a significant difference of BSV from zero (P 
.0001), thus implying the use of a random-effects model.
The linear regression test of Egger and associates21 revealed
no indication for publication bias (intercept, 0.41; P  .98).
The range of weighted mean differences assessed by means
of jackknife sensitivity analysis is calculated as 42.8 to
Subject type
Infarct size (%)
 SD (ICSO)
Infarct size (%)
 SD (control)
Mongrel dogs 56.0 25.2 99.0 10.4
Mongrel dogs 84.0 15.0 100.0 15.0
Mongrel dogs 30.0 21.2 75.0 10.6
Mongrel dogs 39.0 13.2 69.0 16.7
Yorkshire pigs 78.0 10.2 86.3 7.5
Adult pigs 27.0 12.6 73.0 12.6
Adult pigs 27.0 7.3 49.0 11.1
erfusion of arterial blood on myocardial infarct size
Subject type
Infarct size (%)
 SD (ICSO 
retroperf)
Infarct size (%)
 SD (control)
orkshire pigs 44.1 12.9 86.3 7.5
dult pigs 18.0 6.3 73.0 12.6
orkshire pigs 41.5 15.0 80.5 6.1
dult pigs 24.9 4.8 48.5 11.0
orkshire pigs 14.0 3.1 51.0 2.2
l blood.
yocardial infarct sizesize
ol)
etrop
Y
A
Y
A
Y
rteriaon m35.7 (weighted mean difference between the treatment
and Cardiovascular Surgery ● Volume 127, Number 6 1707
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CSPand control groups remained significant for all jackknife
calculations, P  .001). The Thompson plot showed mod-
erate dependence of the weighted mean difference on the
used weighting scheme only on the left extreme (ie, in case
of fixed effects analysis; note the scale of the y-axis).
Comparison of the pooled mean difference between the
ICSO and control groups with the pooled mean difference
between the retrograde perfusion and control groups re-
vealed no significant difference between ICSO and ICSO in
combination with retroperfusion of arterial blood (z 
Figure 1. Thompson plot indicating the effect of the ch
placebo treatment: the curve implies dependence of th
(smaller effect estimated in a fixed-effects analysis
significance between the ICSO and control groups rem
of arterial blood versus placebo treatment: the curve im
on the used weighting scheme only on the left extrem1.316, P  .19).
1708 The Journal of Thoracic and Cardiovascular Surgery ● JunA correlation between achieved coronary sinus pressure
per minute (ratio between coronary sinus occlusion and
release) and infarct size showed a negative association in
the ICSO group (r  0.70; P  .7). Significance could be
reached after eliminating the results reported by Zalewski
and colleagues,27 which apparently do not fit into the overall
reported spectrum of evidence (r  0.92; P  .007).
In contrast to the relationship of pressure increase and
salvage potential in the ICSO group, ICSO in combination
with retroperfusion resulted both in a negative correlation
of statistical method on the analysis. A, ICSO versus
ighted mean difference on the used weighting scheme
a weighted mean difference of 24.8; however, the
P < .001). B, ICSO in combination with retroperfusion
modest dependence of the weighted mean difference
, in case of fixed-effects analysis).oice
e we
with
ains,
plies
e (iebetween achieved coronary sinus pressure and the amount
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Pof the retroperfusate and myocardial salvage (r  0.97;
P  .004).
Discussion
Myocardial protection remains a sensitive issue, even in
today’s surgical practice. The technique of beating-heart
surgery needs more than the brief occlusions of coronary
arteries as applied in the interventional catheterization lab-
oratory. According to the level of surgical complexity,
repetitive occlusions in perfusion-dependent areas leave the
myocardium unprotected to the dynamics of the ischemia-
reperfusion injury.
Coronary sinus interventions are known to salvage isch-
emic myocardium, especially by limiting the infarct from its
borders. The primary goal of all these approaches is not only
to restore blood flow in the occluded vessels but also to
salvage the damaged myocardium. In this study we system-
atically reviewed available data on coronary sinus interven-
tions and performed 2 separate meta-analyses on the effi-
cacy of ICSO alone and ICSO in combination with
retroperfusion of arterial blood in reducing the area of
infarction during acute ischemia assessed as a percentage of
area at risk. We found an overall positive treatment response
of ICSO in both analyses, with a reduction of 29.3% in
animals undergoing ICSO versus a reduction of 39.4% in
animals undergoing ICSO in combination with retroperfu-
sion, both in comparison with the control group. Although
both interventions significantly reduce infarct size and the
fact that no further significance can be reached between the
two methods, the available statistical data do not allow a
further discrimination and are not helpful in determining
which of the methods is superior.
The efficacy of ICSO in salvaging the ischemic myocar-
TABLE 4. Effects of intermittent coronary sinus occlusi
myocardial infarct sizedium during acute ischemia has been a matter of contro-
The Journal of Thoracicversy for many years. Whereas the mechanism of retrograde
coronary sinus perfusion of arterial blood and its positive
effect on reducing the infarct size generally seem to be
easily understood, doubts still remain regarding how a pres-
sure increase in the coronary venous bed induced by ICSO
alone might reduce the area of necrosis without any addi-
tional oxygen supply. In addition, ICSO summarizes a co-
hort of different methods, including variations in the timing
of occlusions and the achieved pressures.
On the other hand, in interventions with retroperfusion of
arterial blood, one would expect a diffusion of oxygen with
subsequent salvage in a Krogh-like pattern from large veins
throughout the infarct zone. This, however, does not seem to
be the case because in both types of intervention, the pattern
of myocardial salvage seems to be the reduction of the
infarct zone from its borders. It is known that occlusion of
the coronary sinus increases the coronary sinus pressure to
levels greater than the distal coronary artery pressure, thus
establishing a gradient for venous flow from the coronary
sinus to the ischemic region when the coronary sinus is
being occluded. It is well known that a desaturation of blood
in the ligated coronary artery occurs according to a veno-
arterial pressure gradient and reversal of flow at the micro-
circulatory level. Pressure forces within the ischemic vas-
cular bed caused by alternating flow over the ischemic
territory also influence perfusion of the ischemic region
from nonischemic myocardium and result in delivery of
small amounts of oxygen through collaterals and further
enhance the removal of toxic metabolites in the deflation
interval.28 Bayer and associates29 showed that the coronary
sinus pressure was an important determinant of desaturation
in the occluded artery, supporting the hypothesis that the
degree of perfusion achieved with ICSO depends on coro-
n combination with retroperfusion of arterial blood onon inary sinus pressure. Thus because of the pressure gradient,
and Cardiovascular Surgery ● Volume 127, Number 6 1709
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relatively empty coronary venous system in the ischemic
zone. The sudden release of the coronary sinus occlusion
results in a rapid drainage of the excessive volume not only
from the well-perfused zones but also from the microvas-
culature recruited during the balloon occlusion phase, al-
lowing an optimal washout of metabolites.
Zalewski and colleagues27 reported on the effects of
various modalities of myocardial protection devices on the
extent of myocardial salvage in an experimental model,
with 7 different groups undergoing different protection
techniques, including retrograde perfusion and ICSO. They
concluded that only arterialization of the cardiac venous
system, and not retroperfusion with venous blood or pres-
sure-controlled intermittent occlusion of the great cardiac
vein, was capable of reducing the size of the infarction.
However, their analysis also revealed higher rates of com-
plications in terms of myocardial hemorrhage in animals
undergoing high-flow retroperfusion, which was explained
as a consequence of the impaired drainage from the ret-
roperfused region of the myocardium. This potential side
effect of retrograde perfusion has also been previously
described by other authors.3,30,31 Furthermore, on the basis
of xenon-133 injections in the great cardiac veins of dogs
subjected to arterial blood retroperfusion in the presence of
left anterior descending coronary artery occlusion, Cohen
and coworkers32 describe that only 10% of the injected
isotope actually reaches the myocardium distal to the cor-
onary occlusion site, suggesting that the delivery of oxy-
genated blood might be insufficient as an additional nutri-
tional support to the ischemic myocardium. Thus the
question arises of whether the beneficial effects found in
several trials with active retroperfusion might have been
related to the high coronary sinus pressures achieved as a
result of retroperfusion and therefore were caused by an
increase of outflow impedance and not necessarily by the
substantial delivery of oxygen into the ischemic bed.
In our meta-analysis we found that although retroperfusion
with arterial blood resulted in 10.2% greater salvage than
intermittent occlusion of the coronary sinus, this difference
was not significant. Although, as stated above, the small sam-
ple size does not allow a definite answer, pathophysiologic
considerations might imply that an arterial blood source might
not be necessary to protect jeopardized myocardium, espe-
cially in consideration of the fact that active retroperfusion is
associated with higher rates of complications caused by un-
controlled impedance to venous outflow.
Mohl and coworkers20 describe the use of coronary sinus
pressure as an important parameter to optimize occlusion-
release cycles of the venous effluence. The coronary artery
flow during coronary sinus occlusion is reduced according
to the pressure increase in the venous circulation, while the
plateau of the systolic pressure increase is reached. This
1710 The Journal of Thoracic and Cardiovascular Surgery ● Junreduction of flow is overpaid by a hyperemic response–like
flow increment. Mohl and coworkers20 have documented
that an occlusion of the coronary sinus through inflation of
the balloon for 15  4 seconds generates a plateau in
coronary sinus pressure. An inflation time of 10 seconds to
obtain this plateau has also been reported previously.33 In
contrast, Feindel and associates34 describe an occlusion of
the coronary sinus for only 5 seconds, which by no means
is sufficient to reach a pressure plateau and might thus
explain why their experiments revealed no favorable results
for ICSO (achieved coronary sinus pressure during coronary
sinus occlusion in trials of Feindel and associates34: 17.1 
6.4 mm Hg; achieved coronary sinus pressure during coro-
nary sinus occlusion in trials of Mohl and coworkers20: 44.0
 7.0 mm Hg). This is about the same pressure Feindel and
associates34 reached in their retroperfusion studies resulting
in significant salvage. In contrast, Aldea and colleagues,13
who achieved about the same coronary sinus pressure with
both methods, also reported similar salvage in both groups.
The smaller amount of salvage in some of the ICSO studies
therefore might be explained by the insufficient filling of the
coronary venous system to allow redistribution of blood in
significant quantities from the nonischemic myocardium to
the ischemic zone, thus preventing an optimal recruitment
of collaterals.
The negative association between remaining infarct size
and the achieved coronary sinus pressure in the ICSO group
suggest the potential of the transient pressurization of the
venous compartment in inducing myocardial salvage, al-
though results have to be interpreted with caution because
of the lack of raw data. Furthermore, the results of the
negative correlation between achieved coronary sinus pres-
sure and myocardial salvage during the addition of active
retroperfusion can be interpreted as a potential hazard of
this method. This can be seen also in the relationship to the
amount of retroperfusate.
The seeming contradiction of the relationship between
pressure and salvage potential comes as a surprise only at a
first glance because the pressure in the ICSO group is only
the consequence of myocardial contraction on the venous
compartment during coronary sinus occlusion, whereas the
pressure observed in the ICSO plus retroperfusion group is
the consequence of summing the intramyocardial pressure
acting on the venous compartment and the external pumping
force of the retroperfusate. It is therefore no surprise that the
potential hazard of myocardial hemorrhage can be seen in
active retroperfusion.27 It seems that 2 factors act in oppo-
sition: first, the ability of the pressure increase to induce
myocardial salvage, and second, the improper timing of
outflow impedance leading to the engorgement of the cor-
onary microcirculation, thus reducing positive results by
inducing severe changes of coronary artery flow, myocar-
e 2004
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Pdial hemorrhage, edema formation, and subsequent decrease
of myocardial performance.
Our own experience with coronary sinus interventions in
a clinical setting applying PICSO during the early reperfu-
sion period showed improvements also in regional myocar-
dial function.35 PICSO was applied in 15 patients with
3-vessel disease undergoing on-pump coronary artery by-
pass grafting for about 60 minutes during the reperfusion
period, and the results were compared with those of 15 control
subjects. A significant improvement of regional function in
hypokinetic segments (P .04 treated vs control subjects) was
found. In addition, severely hypokinetic segments significantly
improved during PICSO therapy from prebypass values (P 
.01), whereas in control subjects these changes were not sig-
nificant. With this relatively simple method using a balloon
catheter in the coronary sinus without additional blood supply,
one can expect a reduction in myocardial jeopardy during
beating-heart surgery.
In conclusion, this meta-analysis demonstrates that myo-
cardial protection through the coronary sinus has an efficacy
in reducing the size of experimental myocardial infarction
irrespective of the time of ischemia and subsequent revas-
cularization procedures. Active retroperfusion, with its
known difficulties, resulted in an insignificant further reduc-
tion of the experimental infarct size in comparison with
intermittent occlusion of the coronary sinus alone. In addi-
tion, these results show the importance of a physiologic
adaptation of the coronary venous pressure increase, as well
as the amount of the retroperfusate, to optimize the salvage
potential and to minimize the consequences of the potential
hazard of myocardial engorgement.
Evaluation of the effects on transient ventricularization
of the venous vasculature as a consequence of all known
coronary sinus interventions seems to be the logical next
step to improve our understanding on the salvage potential
of these methods.
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